Cargando…

Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer

Background: Cancer stem cells (CSCs) are involved in tumor progression and drug resistance. We hypothesized that variants in CSC marker genes influence treatment outcomes in prostate cancer. Methods: Ten potentially functional single nucleotide polymorphisms (SNPs) in seven prostate CSC marker genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Victor C., Huang, Shu-Pin, Huang, Chao-Yuan, Yu, Chia-Cheng, Yin, Hsin-Ling, Huang, Tsung-Yi, Lee, Cheng-Hsueh, Lu, Te-Ling, Bao, Bo-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666565/ https://www.ncbi.nlm.nih.gov/pubmed/29104488 http://dx.doi.org/10.7150/ijms.21428

Ejemplares similares

Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy
por: Yu, Chia‐Cheng, et al.
Publicado: (2019)

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy
por: Lee, Cheng-Hsueh, et al.
Publicado: (2016)

Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer
por: Huang, Chao-Yuan, et al.
Publicado: (2015)

Genetic Interaction Analysis of TCF7L2 for Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer
por: Chen, Chien-Shu, et al.
Publicado: (2015)

Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival
por: Bao, Bo-Ying, et al.
Publicado: (2016)

Vitamin D receptor-binding site variants affect prostate cancer progression
por: Lin, Victor C., et al.
Publicado: (2017)

A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer
por: Huang, Eric Y., et al.
Publicado: (2018)

NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
por: Huang, Shu-Pin, et al.
Publicado: (2021)

Prognostic Value of CD1B in Localised Prostate Cancer
por: Lee, Cheng-Hsueh, et al.
Publicado: (2019)

Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer
por: Huang, Chao-Yuan, et al.
Publicado: (2015)

Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
por: Yu, Chia-Cheng, et al.
Publicado: (2019)

Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy
por: Geng, Jiun-Hung, et al.
Publicado: (2016)

Genetic association analysis identifies a role for ANO5 in prostate cancer progression
por: Yu, Chia‐Cheng, et al.
Publicado: (2020)

Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
por: Lu, Yu-Cheng, et al.
Publicado: (2022)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

TNFRSF13B is a potential contributor to prostate cancer
por: Li, Chia-Yang, et al.
Publicado: (2022)

Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer
por: Chang, Hao-Han, et al.
Publicado: (2022)

Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
por: Tseng, Chi-Shin, et al.
Publicado: (2021)

Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
por: Lin, Victor C., et al.
Publicado: (2016)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
por: Patel, Parth, et al.
Publicado: (2015)

UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy
por: Wan, Xuechao, et al.
Publicado: (2016)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
por: Axén, Elin, et al.
Publicado: (2021)

Influence of serum total cholesterol, LDL, HDL, and triglyceride on prostate cancer recurrence after radical prostatectomy
por: Cheng, Sheng, et al.
Publicado: (2019)

Genetic Analysis Reveals a Significant Contribution of CES1 to Prostate Cancer Progression in Taiwanese Men
por: Ke, Chien-Chih, et al.
Publicado: (2020)

Multiparametric MRI for Recurrent Prostate Cancer Post Radical Prostatectomy and Postradiation Therapy
por: Barchetti, Flavio, et al.
Publicado: (2014)

Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
por: Kim, Dong Soo, et al.
Publicado: (2015)

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
por: Geybels, Milan S., et al.
Publicado: (2016)

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients
por: Gu, Cheng-Yuan, et al.
Publicado: (2016)

A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy
por: Li, Xiang, et al.
Publicado: (2020)

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
por: Shiraishi, Takumi, et al.
Publicado: (2011)

The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Advanced Imaging for the Early Diagnosis of Local Recurrence Prostate Cancer after Radical Prostatectomy
por: Panebianco, Valeria, et al.
Publicado: (2014)

Prostate Cancer Biochemical Recurrence Rates After Robotic-Assisted Laparoscopic Radical Prostatectomy
por: Ginzburg, Serge, et al.
Publicado: (2012)

Management of biochemical recurrence after radical prostatectomy for prostate cancer: A case report
por: Shen, Jiayan, et al.
Publicado: (2019)

Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy
por: Park, Jihwan, et al.
Publicado: (2021)

Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
por: Cheng, Yung-Ting, et al.
Publicado: (2020)

Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
por: Jin, Kun, et al.
Publicado: (2019)

Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance
por: Yang, Che Hseuh, et al.
Publicado: (2021)

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pd0oe6ut1fhbosv1l89v3njppf